References
- Monreal M, Suarez CJ, Fajardo AJ, et al. Management of patients with acute venous thromboembolism: findings from the RIETE registry. Pathophysiol Haemost Thromb. 2004;33:330–334. doi:10.1159/000083823
- Schünemann HJ, Cushman M, Burnett AE, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018;2:3198–3225.30482763
- Di Micco LC. Idiopathic Venous Thromboembolism (VTE) American Society of Hematology 2018 and its association to rare molecular clotting abnormalities. Health Sci J. 2018;12:e15.
- Nomura S, Ito T, Yoshimura H, et al. Evaluation of thrombosis-related biomarkers before and after therapy in patients with multiple myeloma. J Blood Med. 2018;9:1. doi:10.2147/JBM.S14774329403323
- Besser MW, MacDonald SG. Acquired hypofibrinogenemia: current perspectives. J Blood Med. 2016;26(7):217–225. doi:10.2147/JBM.S90693
- Hayward CPM. How I investigate for bleeding disorders. Int J Lab Hematol. 2018;40(Suppl 1):6–14. doi:10.1111/ijlh.2018.40.issue-S129741250
- Jain S, Donkin J, Frey MJ, Peltier S, Gunawardena S, Cooper DL. Phenotypical variability in congenital FVII deficiency follows the ISTH-SSC severity classification guidelines: a review with illustrative examples from the clinic. J Blood Med. 2018;9:211–218. doi:10.2147/JBM.S15763330510462
- Scudiero O, Gentile L, Ranieri A, et al. Physical activity and thrombophilic risk in a short series. J Blood Med. In press 2020.
- Di Micco P, Gussoni G, Pieralli F, Campanini M, Fontanella A. Acquired factor XIII deficiency inducing recurrent and fatal bleeding, description of a case. J Blood Med. In press 2020.
- Galbiati G. Successful cerebral hemorrhage treatment with prothrombin complex concentrate in a patient with edoxaban therapy: a case report. J Blood Med. In press 2020.